Methyclothiazide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for methyclothiazide and what is the scope of patent protection?

Methyclothiazide is the generic ingredient in five branded drugs marketed by Medpointe Pharm Hlc, Abbvie, Chartwell Rx, Ivax Pharms, Mylan, Mylan Pharms Inc, Par Pharm, Usl Pharma, Watson Labs, and Abbott, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for methyclothiazide.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Pharm	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	089136-001	Feb 12, 1986		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	089837-001	Aug 18, 1988		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Usl Pharma	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	088745-001	Mar 21, 1985		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Medpointe Pharm Hlc	AQUATENSEN	methyclothiazide	TABLET;ORAL	017364-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Abbott	EUTRON	methyclothiazide; pargyline hydrochloride	TABLET;ORAL	016047-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	5
Applicants:	10
NDAs:	17
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	68
Patent Applications:	6,952
DailyMed Link:	methyclothiazide at DailyMed